PATENT CLAIM ANALYSIS

Application Number: 16074750
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "025000"]

Abstract:
Provided are compounds generated by conjugation of triptolide with glucose to form glucose-triptolide conjugates, provides compounds with effective anti-proliferative activity and improved tolerability as compared to naturally occurring triptolide compounds.

Claim (Index 28):
The method of  claim 27 , wherein the compound is administered intravenously.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 96.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12575425', '14436387', '15114895', '15737683', '11617651']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779470669981061
- 35 USC 102 Novelty (BERT): 0.5202382339853548
- Combined Prediction Score: 0.7535474263814904
- Mean Citation Score: 291.97641
- Max Citation Score: 319.12393
- Similarity Product: 237.75693511228727

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test